Singapore Exchange Ltd (SGX)

Singapore Exchange is Asia’s leading and trusted market infrastructure, facilitating the exchange of capital and ideas to create value for people, businesses and economies. As a multi-asset exchange operating equity, fixed income and derivatives markets to the highest regulatory standards, SGX is a vertically integrated business that provides listing, trading, clearing, settlement, depository and data services.

With about 40% of listed companies and over 80% of listed bonds originating outside of Singapore as well as established linkages across the region and in Europe, SGX is Asia’s most international and connected exchange. Offering a full suite of derivatives products across Asian equity indices, commodities and currencies, SGX is the world’s most liquid international market for the benchmark equity indices of China, India, Japan and ASEAN.

As Asia’s pioneering central counterparty, SGX is globally recognised for its risk management and clearing capabilities, and was one of the first globally to adopt the Principles for Financial Market Infrastructure.

Headquartered in AAA-rated Singapore, SGX has over 800 employees including offices in Beijing, Chicago, Hong Kong, London, New York, Mumbai, San Francisco, Shanghai and Tokyo.

Asia’s leading multi-asset exchange

SGX Market Strategist, Equity & Fixed Income, Singapore Exchange Ltd (SGX)

Geoff Howie

SGX Market Strategist, Equity & Fixed Income

Thematic (Sector/Industry)

Indonesia Health care / Thematic (Sector/Industry)

<ul><li>Singapore lists comparatively more stocks in the GICS® ‘Healthcare Providers and Services’ sub-sector than the global norm, with capitalisation growth outpacing the world.</li><li>Singapore's 14 primary listings in the sub-sector generated a 12M median return of 24% (or 45% average gain excluding new listing HC Surgical Specialists' 115% gain on its initial offer price).</li><li>Four of the 14 primary listings - Singapore Medical Group, Health Management International, TalkMed Group and Singapore O&amp;G - exceeded 50% in 12M returns. The majority of the four stocks reported profit growth for either the 6M or 12M ending 31 Dec 2016 with significant increases in 12M turnover activity. </li></ul>

Singapore lists comparatively more stocks in the GICS® ‘Healthcare Providers and Services’ sub-sector than the global norm, with capitalisation growth outpacing the world.Singapore's 14 primary listings in the sub-sector generated a 12M median return of 24% (or 45% average gain excluding new listing HC Surgical Specialists' 115% gain on its initial offer price).Four of the 14 primary listings - Singapore Medical Group, Health Management International, TalkMed Group and Singapore O&amp;G - exceeded 50% in 12M returns. The majority of the four stocks reported profit growth for either the 6M or 12M ending 31 Dec 2016 with significant increases in 12M turnover activity. 

Singapore's Strongest Performing Healthcare Providers of Past Year